Innate Pharma SA
Adrien Bourbonnais is an accomplished professional with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as Director and Head of CMC Pharmaceutical Operations & Supply Chain at Innate Pharma since October 2019, Adrien leads a diverse team while overseeing a substantial budget and managing complex projects from development to clinical supply. Prior to that, Adrien held senior project management roles at Innate Pharma focusing on CMC project management for biologics and has comprehensive experience in process development, regulatory interactions, and clinical manufacturing across multiple regions including the US, EU, and Asia. Adrien's previous roles include significant leadership positions at Virbac and Merck, emphasizing process and quality improvements in various manufacturing environments. Adrien holds a diploma in Bio-industry Engineering from École de Biologie Industrielle and possesses proficiency in multiple software tools essential for project and process management.
This person is not in the org chart
This person is not in any offices
Innate Pharma SA
2 followers
Innate Pharma SA is a France-based biopharmaceutical Company that develops drugs for treatment of cancer and inflammatory diseases. The Company identifies and characterizes drug candidates, selects indications and manages the pre-clinical and clinical development of products. Innate Pharma primarily focuses on the development of new therapeutic solutions and monoclonal antibodies for the treatment of cancer, as well as for the treatment of infectious diseases and chronic inflammatory pathologies. The Company develops two categories of immunotherapies: immuno-modulators and cytotoxic antibodies. The Company works in collaboration with Bristol-Myers Squibb for Phase I cancer antibody program and with Novo Nordisk A/S for two antibody programs in inflammation treatment. The Company operates through anti-NKG2A antibody, an immune checkpoint inhibitor ready for Phase II development in oncology from Novo Nordisk.